Fabrizio Galimberti, MD, PhD: The Importance of Targeted Therapy for GPP Treatment

from The Journal of Clinical and Aesthetic Dermatology · host Matrix Medical Communications

Send us Fan MailFabrizio Galimberti, MD, PhD, reviews the molecular biology behind spesolimab for the treatment of generalized pustular psoriasis (GPP). He highlights the distinction between psoriasis and GPP, while discussing the role that the interleukin-36 pathway plays in inflammation. Dr. Galimberti emphasizes the importance of targeted treatment for flare reduction and improved outcomes in GPP management.

Episode metadata supplied by the publisher feed · Published Jul 1, 2026

Embed this episode

Attribution link and audio player

Ready to play

Fabrizio Galimberti, MD, PhD: The Importance of Targeted Therapy for GPP Treatment

0:00 7:36

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Journal of Clinical and Aesthetic Dermatology?

This episode is 7 minutes long.

When was this The Journal of Clinical and Aesthetic Dermatology episode published?

This episode was published on July 1, 2026.

Can I download this The Journal of Clinical and Aesthetic Dermatology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!